Financial Information
Tax Information Letter
Form 10 Information Statement
Myriad Genetics, Inc.'s latest financial information is provided below. We are a July 1 to June 30 fiscal year company.
| Latest Earnings Release and 10-Q | Date Filed | Format | Size |
|---|---|---|---|
| Third Quarter Financial Results |  |
N/A | |
| Form 10-Q | May 8, 2013 | 
|
285.7 KB |
| Form 10-Q | Feb 6, 2013 |
|
288.0 KB |
| Latest Annual Report and 10-K | Date Filed | Format | Size |
| Annual Report 2012 |
|
970.9 KB | |
| Form 10-K | Aug 15, 2012 |
|
930.0 KB |
| Latest Proxy Statement | Date Filed | Format | Size |
| Proxy Statement (DEFA14A) | Oct 12, 2012 |
|
39.8 KB |
| Proxy Statement | Oct 12, 2012 |
|
894.8 KB |
Stock Quote (NASDAQ:MYGN)
Price:
25.88
Change:
- 0.56
Open:
26.32
Previous Close:
26.44
Day High:
27.11
Day Low:
25.79
52 Week High:
38.27
52 Week Low:
22.02
Volume:
2,812,300
4:02 PM ET on Jun 19, 2013
Delayed at least 20 minutes.
Provided by eSignal.
Provided by eSignal.
Investor Contact
Scott Gleason
(801) 584-1143
sgleason@myriad.com
Media Contact
Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com
